IRIS UniCatt

Tumbarello, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.334
EU - Europa 10.369
AS - Asia 9.044
SA - Sud America 1.582
AF - Africa 243
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 32.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.073
DE - Germania 4.210
SG - Singapore 3.845
CN - Cina 2.903
BR - Brasile 1.276
SE - Svezia 1.220
IT - Italia 988
UA - Ucraina 842
FR - Francia 827
VN - Vietnam 634
PL - Polonia 549
GB - Regno Unito 457
IE - Irlanda 374
IN - India 303
FI - Finlandia 272
TR - Turchia 267
ID - Indonesia 259
RU - Federazione Russa 212
HK - Hong Kong 169
JP - Giappone 147
AR - Argentina 118
BD - Bangladesh 116
CA - Canada 109
MX - Messico 97
IQ - Iraq 78
ZA - Sudafrica 70
NL - Olanda 67
AT - Austria 55
ES - Italia 54
BE - Belgio 53
EC - Ecuador 49
MA - Marocco 43
CO - Colombia 36
SA - Arabia Saudita 33
PK - Pakistan 31
VE - Venezuela 29
IR - Iran 26
UZ - Uzbekistan 25
IL - Israele 23
PH - Filippine 22
RO - Romania 22
TN - Tunisia 21
KR - Corea 20
CH - Svizzera 19
EG - Egitto 19
LT - Lituania 19
AE - Emirati Arabi Uniti 18
JO - Giordania 18
CL - Cile 17
KE - Kenya 17
AU - Australia 16
PE - Perù 16
CZ - Repubblica Ceca 15
UY - Uruguay 15
BO - Bolivia 14
BG - Bulgaria 13
GR - Grecia 13
KZ - Kazakistan 13
EU - Europa 12
HU - Ungheria 12
CI - Costa d'Avorio 11
DZ - Algeria 11
ET - Etiopia 11
JM - Giamaica 10
NP - Nepal 10
AL - Albania 9
HN - Honduras 9
LY - Libia 9
PY - Paraguay 9
AZ - Azerbaigian 8
LV - Lettonia 8
OM - Oman 8
PT - Portogallo 8
BZ - Belize 7
CR - Costa Rica 7
HR - Croazia 7
MY - Malesia 7
TH - Thailandia 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
NG - Nigeria 6
RS - Serbia 6
BH - Bahrain 5
KG - Kirghizistan 5
MD - Moldavia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
VA - Santa Sede (Città del Vaticano) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LB - Libano 4
LK - Sri Lanka 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
Totale 32.544
Salva come PNG Salva come JPEG
Città #
Singapore 2.000
Chandler 1.512
Ashburn 1.157
San Jose 903
Hangzhou 626
Jacksonville 573
Beijing 432
Warsaw 429
San Mateo 398
Nanjing 376
Dublin 369
Ann Arbor 355
Dearborn 302
Woodbridge 267
Nürnberg 266
Wilmington 265
New York 258
Jakarta 235
Los Angeles 232
Izmir 207
Ho Chi Minh City 206
Lauterbourg 202
Houston 194
Boston 176
Munich 163
Hanoi 161
Hefei 159
Hong Kong 154
The Dalles 150
Milan 146
Lawrence 140
Fairfield 138
Moscow 137
Seattle 136
Frankfurt am Main 133
Tokyo 131
São Paulo 128
Nanchang 127
Cattolica 123
Marseille 120
Chicago 109
Rome 106
Kraków 104
Redwood City 104
Buffalo 91
Princeton 80
Shenyang 73
Dallas 72
Guangzhou 71
Kunming 70
Tianjin 67
Bremen 65
Santa Clara 63
Mountain View 62
Hebei 61
Boardman 59
Lancaster 58
Helsinki 56
Brussels 53
Norwalk 53
Zhengzhou 51
St Louis 49
London 47
University Park 47
Brooklyn 43
Cambridge 43
Changsha 41
Jiaxing 41
Orem 41
Paris 40
Redmond 40
Shanghai 38
Falls Church 36
Kent 36
Rio de Janeiro 36
Baghdad 35
Da Nang 35
Toronto 34
Vienna 34
Johannesburg 33
Nuremberg 32
Council Bluffs 31
Fremont 31
Jinan 31
Montreal 31
Pune 31
Phoenix 29
Belo Horizonte 28
Leawood 28
Chennai 27
San Francisco 27
Dhaka 26
Haiphong 26
Amsterdam 24
Augusta 22
Brasília 22
Hyderabad 22
Tashkent 22
Campinas 21
Denver 21
Totale 16.995
Salva come PNG Salva come JPEG
Nome #
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 395
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 357
Factors associated with mortality in bacteremic patients with haematologic malignancies 355
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 355
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 353
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 311
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 307
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 306
A prospective survey of febrile events in hematological malignancies 302
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 293
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 279
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 277
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 276
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 260
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 255
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 246
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 246
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 238
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 234
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 229
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 220
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Whole-genome sequencing reveals host factors underlying critical COVID-19 216
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 212
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 205
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 205
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 201
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 197
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 194
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 193
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 192
Safety and effectiveness of transvenous lead extraction in octogenarians 191
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 189
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 188
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 186
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 182
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 181
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 180
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 180
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 180
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 180
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 179
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 177
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 176
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 176
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 175
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 174
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 171
Neurological involvement during legionellosis, look beyond the lung 171
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 170
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 169
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 169
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 168
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 166
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 164
An explainable model of host genetic interactions linked to COVID-19 severity 164
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 164
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 163
Attitudes and practices of dentists treating HIV patients in HAART era. 161
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 159
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 159
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 159
Oral lesions in HIV and HCV co-infected individuals in HAART era 155
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 154
A prospective survey of febrile events in hematological malignancies 154
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 154
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 153
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 153
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 151
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 151
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 151
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 150
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 149
A prospective survey of febrile events in hematological malignancies 149
Neurological involvement during Legionellosis, look beyond the lung 149
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 148
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 148
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 148
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 148
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 148
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 147
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 147
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 146
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 146
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 146
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 145
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 145
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 145
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 144
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 143
Oral lesions in HIV and HCV co-infected individuals in HAART era 142
Mortality in patients with early- or late-onset candidaemia 142
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories 140
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 140
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 139
Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators 138
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 138
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 138
Totale 19.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021440 0 0 0 0 0 0 0 0 0 68 310 62
2021/20222.069 194 189 63 114 117 110 37 360 90 133 264 398
2022/20234.027 472 553 312 575 286 512 174 316 490 121 151 65
2023/20241.755 107 578 45 82 53 224 105 73 27 58 172 231
2024/20253.784 116 131 286 139 391 116 122 201 606 326 715 635
2025/20269.482 1.571 279 514 1.071 1.902 533 1.788 511 655 658 0 0
Totale 32.926